Citation Tools
PDFRegular and Young Investigator Award Abstracts
Cellular Therapies
340 TGFβDNRII genetically-engineered TIL: characterizing final drug product from a phase I clinical trial
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 340 TGFβDNRII genetically-engineered TIL: characterizing final drug product from a phase I clinical trial